Literature DB >> 8254693

Primary aldosteronism caused by an adrenal tumor: a correctable cause of hypertension.

R J Smith, W L Faulkner.   

Abstract

Primary aldosteronism due to an adrenal tumor is rare. When found, it can be treated surgically and cured. This is a case report of a 41-year-old man with a long history of severe hypertension who complained of weakness and weight loss. Laboratory studies revealed hypokalemia and marked elevation of the serum aldosterone level. A computed tomography scan revealed a left adrenal mass that increased in size over 3 months' time. A left adrenalectomy was done, and the patient has had a dramatic decrease in his blood pressure and has returned to work.

Entities:  

Mesh:

Year:  1993        PMID: 8254693      PMCID: PMC2568222     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  5 in total

1.  Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.

Authors:  J W CONN
Journal:  J Lab Clin Med       Date:  1955-01

2.  Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle.

Authors:  J E Sealey; I Cholst; N Glorioso; C Troffa; I D Weintraub; G James; J H Laragh
Journal:  J Clin Endocrinol Metab       Date:  1987-07       Impact factor: 5.958

3.  The blood pressure response to unilateral adrenalectomy in primary aldosteronism.

Authors:  S R Milsom; E A Espiner; M G Nicholls; J Gwynne; E G Perry
Journal:  Q J Med       Date:  1986-12

4.  Selection of patients and operative approach in primary aldosteronism.

Authors:  T K Hunt; M Schambelan; E G Biglieri
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

5.  Primary aldosteronism: changing concepts in diagnosis and management.

Authors:  R C Lim; D K Nakayama; E G Biglieri; M Schambelan; T K Hunt
Journal:  Am J Surg       Date:  1986-07       Impact factor: 2.565

  5 in total
  1 in total

1.  Symptomatic hypocalcemia in primary hyperaldosteronism: a case report.

Authors:  Sachin G Pai; K N Shivashankara; V Pandit; S Sheshadri
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.